Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.

Zuern CS, Müller KA, Seizer P, Geisler T, Banya W, Klingel K, Kandolf R, Bauer A, Gawaz M, May AE.

Eur J Heart Fail. 2013 Feb;15(2):176-84. doi: 10.1093/eurjhf/hfs185. Epub 2012 Dec 12.

2.

CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure.

Borst O, Schaub M, Walker B, Sauter M, Muenzer P, Gramlich M, Mueller K, Geisler T, Lang F, Klingel K, Kandolf R, Bigalke B, Gawaz M, Zuern CS.

Int J Cardiol. 2014 Oct 20;176(3):896-903. doi: 10.1016/j.ijcard.2014.08.033. Epub 2014 Aug 13.

PMID:
25223819
3.

Predictors of outcome in patients with suspected myocarditis.

Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M.

Circulation. 2008 Aug 5;118(6):639-48. doi: 10.1161/CIRCULATIONAHA.108.769489. Epub 2008 Jul 21. Erratum in: Circulation.2008 Sep 16;118(12): e493.

4.

EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy.

Seizer P, Geisler T, Bigalke B, Schneider M, Klingel K, Kandolf R, Stellos K, Schreieck J, Gawaz M, May AE.

Int J Cardiol. 2013 Mar 10;163(3):299-304. doi: 10.1016/j.ijcard.2011.06.049. Epub 2011 Jul 2.

PMID:
21724278
5.

Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.

Arbustini E, Gavazzi A, Dal Bello B, Morbini P, Campana C, Diegoli M, Grasso M, Fasani R, Banchieri N, Porcu E, Pilotto A, Ponzetta M, Bellini O, Lucreziotti S, Viganò M.

G Ital Cardiol. 1997 Mar;27(3):209-23.

PMID:
9199949
6.

Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy.

Mueller KA, Tavlaki E, Schneider M, Jorbenadze R, Geisler T, Kandolf R, Gawaz M, Mueller II, Zuern CS.

J Card Fail. 2013 Oct;19(10):678-84. doi: 10.1016/j.cardfail.2013.09.001.

PMID:
24125106
7.

[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].

Pauschinger M, Kühl U, Dörner A, Schieferecke K, Petschauer S, Rauch U, Schwimmbeck PL, Kandolf R, Schultheiss HP.

Z Kardiol. 1998 Jun;87(6):443-52. German.

PMID:
9691414
8.

Right Ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients.

Nippoldt TB, Edwards WD, Holmes DR Jr, Reeder GS, Hartzler GO, Smith HC.

Mayo Clin Proc. 1982 Jul;57(7):407-18.

PMID:
6211578
10.

Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery.

Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H.

J Am Coll Cardiol. 2012 May 1;59(18):1604-15. doi: 10.1016/j.jacc.2012.01.007. Epub 2012 Feb 22.

11.

Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra?

Becker AE, Heijmans CD, Essed CE.

Eur Heart J. 1991 Feb;12(2):218-23.

PMID:
2044556
12.
13.

Detection of viral and bacterial protein in endomyocardial biopsies of patients with inflammatory heart muscle disease?

Davydova J, Pankuweit S, Crombach M, Eckhardt H, Strache D, Faulhammer P, Maisch B.

Herz. 2000 May;25(3):233-9.

PMID:
10904844
14.

Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis?

Narula J, Chopra P, Talwar KK, Reddy KS, Vasan RS, Tandon R, Bhatia ML, Southern JF.

Circulation. 1993 Nov;88(5 Pt 1):2198-205.

PMID:
8222115
15.

Endomyocardial biopsy in patients with unexplained congestive heart failure.

Chow LC, Dittrich HC, Shabetai R.

Ann Intern Med. 1988 Oct 1;109(7):535-9.

PMID:
3421562
16.

Blood pressure and heart rate predict outcome in patients acutely admitted with suspected myocarditis without previous heart failure.

Mahfoud F, Ukena C, Kandolf R, Kindermann M, Böhm M, Kindermann I.

J Hypertens. 2012 Jun;30(6):1217-24. doi: 10.1097/HJH.0b013e328352b9ca.

PMID:
22473019
17.

Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.

Nakahashi T, Arita T, Yamaji K, Inoue K, Yokota T, Hoshii Y, Fukunaga M, Nomura A, Watanabe H, Miura S, Isotani A, Soga Y, Ando K, Iwabuchi M, Yokoi H, Nosaka H, Yamagishi M, Nobuyoshi M.

Int J Cardiol. 2014 Oct 20;176(3):753-9. doi: 10.1016/j.ijcard.2014.07.100. Epub 2014 Aug 2.

PMID:
25131905
18.

Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.

Heidecker B, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Kittleson MM, Baughman KL, Hare JM.

Circulation. 2008 Jul 15;118(3):238-46. doi: 10.1161/CIRCULATIONAHA.107.756544. Epub 2008 Jun 30.

19.

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.

Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L.

Eur Heart J. 2007 Jun;28(11):1326-33. Epub 2007 May 9.

20.

Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy.

Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ.

J Am Coll Cardiol. 1995 Jul;26(1):80-4.

Items per page

Supplemental Content

Write to the Help Desk